Lisa Foster-McNulty

//Lisa Foster-McNulty

About Lisa Foster-McNulty

This author has not yet filled in any details.
So far Lisa Foster-McNulty has created 62 blog entries.

Nasal glucagon: a viable option

By | 2017-07-14T19:21:02+00:00 July 14th, 2017|July 2017 Newsletter|

According to research presented at the annual meeting of the American Diabetes Association (ADA) in June, a new glucagon product is much easier to use than is the traditional formulation for injection. Could this mean that it's more likely that a caregiver would be willing to administer it when needed?

Discount prescription plan could help you save money on diabetes medications

By | 2017-06-14T20:34:17+00:00 June 14th, 2017|June 2017 Newsletter|

I love being able to deliver good news about diabetes…how would you like to be able to save money on insulin or other diabetes medication? Read on to find out if you might be eligible!

Liraglutide use in Type 1 diabetes patients offers multiple benefits

By | 2017-06-14T20:33:53+00:00 June 14th, 2017|June 2017 Newsletter|

According to a study presented at the May 2017 annual meeting of the American Association of Clinical Endocrinologists (AACE), treating people with Type 1 diabetes with liraglutide resulted in lower A1c levels. Liraglutide is better known as Novo Nordisk's Glucagon like peptide-1 receptor agonist (GLP-1RA) Victoza.

Location of insulin delivery matters for Type 1 patients in fully-automated artificial pancreas study

By | 2017-06-22T13:33:22+00:00 June 14th, 2017|June 2017 Newsletter|

We are so accustomed to insulin being delivered to the subcutaneous tissues that it's easy to forget to think outside the box. Fortunately, some researchers have investigated other options, with encouraging results.

Long term Type 1 diabetes not linked to osteoarthritis of hand

By | 2017-06-14T20:33:10+00:00 June 14th, 2017|June 2017 Newsletter|

We are so accustomed to insulin being delivered to the subcutaneous tissues that it's easy to forget to think outside the box. Fortunately, some researchers have investigated other options, with encouraging results.

BG control in Type 1 Diabetes Improves with Fast-Acting Insulin Aspart

By | 2017-05-18T18:17:19+00:00 May 18th, 2017|May 2017 Newsletter|

According to a study published online in Diabetes Care on April 11, fast-acting insulin aspart (faster aspart) improved blood glucose control in patients with Type 1 diabetes, as compared to the conventional formulation of the drug, insulin aspart (IAsp). In the United States, insulin aspart is better known as Novo Nordisk's insulin Novolog. In many other countries, it is known as NovoRapid.

Diabetes Management: Integrated Diabetes Services vs. Clinic based Endocrinologists

By | 2017-05-08T16:40:40+00:00 May 8th, 2017|Thinking Like A Pancreas Blog|

At Integrated Diabetes Services, we have a different setup. Everyone who works at IDS has a personal connection to diabetes. 3 of our clinicians are CDEs who wear insulin pumps and use a CGM, and the 4th is a CDE who is the mother of a child with Type 1.